Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 13373 | 28.225 |
09:34 ET | 100 | 28.235 |
09:36 ET | 5428 | 28.27 |
09:38 ET | 879 | 28.255 |
09:39 ET | 2511 | 28.21 |
09:41 ET | 200 | 28.215 |
09:43 ET | 1045 | 28.215 |
09:45 ET | 4932 | 28.18 |
09:48 ET | 6476 | 28.19 |
09:50 ET | 1741 | 28.175 |
09:52 ET | 1027 | 28.156766 |
09:54 ET | 200 | 28.15 |
09:56 ET | 600 | 28.165 |
09:57 ET | 1458 | 28.15 |
09:59 ET | 5412 | 28.21 |
10:01 ET | 400 | 28.22 |
10:03 ET | 9242 | 28.27 |
10:06 ET | 2298 | 28.275 |
10:08 ET | 1873 | 28.33 |
10:10 ET | 612 | 28.335 |
10:12 ET | 3748 | 28.325 |
10:14 ET | 948 | 28.29 |
10:15 ET | 100 | 28.33 |
10:17 ET | 920 | 28.35 |
10:19 ET | 6546 | 28.32 |
10:21 ET | 100 | 28.315 |
10:24 ET | 5979 | 28.31 |
10:26 ET | 2037 | 28.31 |
10:28 ET | 1907 | 28.32 |
10:30 ET | 767 | 28.28 |
10:32 ET | 2700 | 28.265 |
10:33 ET | 1240 | 28.26 |
10:35 ET | 3721 | 28.27 |
10:37 ET | 3300 | 28.28 |
10:39 ET | 4461 | 28.29 |
10:42 ET | 700 | 28.295 |
10:44 ET | 100 | 28.295 |
10:46 ET | 8360 | 28.295 |
10:48 ET | 605 | 28.295 |
10:50 ET | 1600 | 28.315 |
10:51 ET | 2291 | 28.2847 |
10:53 ET | 100 | 28.28 |
10:55 ET | 1103 | 28.27 |
10:57 ET | 1400 | 28.26 |
11:00 ET | 5333 | 28.25 |
11:02 ET | 2993 | 28.2445 |
11:04 ET | 2019 | 28.2 |
11:06 ET | 1691 | 28.2 |
11:08 ET | 1200 | 28.19 |
11:09 ET | 9266 | 28.185 |
11:11 ET | 2227 | 28.165 |
11:13 ET | 1286 | 28.155 |
11:15 ET | 2175 | 28.12 |
11:18 ET | 5264 | 28.115 |
11:20 ET | 2566 | 28.115 |
11:22 ET | 500 | 28.1128 |
11:24 ET | 2153 | 28.12 |
11:26 ET | 1626 | 28.11 |
11:27 ET | 10475 | 28.09 |
11:29 ET | 4291 | 28.09 |
11:31 ET | 6184 | 28.065 |
11:33 ET | 2102 | 28.08 |
11:36 ET | 2300 | 28.125 |
11:38 ET | 3389 | 28.09 |
11:40 ET | 2455 | 28.1001 |
11:42 ET | 4672 | 28.085 |
11:44 ET | 2500 | 28.08 |
11:45 ET | 300 | 28.08 |
11:47 ET | 6246 | 28.08 |
11:49 ET | 500 | 28.07 |
11:51 ET | 1192 | 28.065 |
11:54 ET | 715 | 28.065 |
11:56 ET | 7032 | 28.075 |
11:58 ET | 5784 | 28.09 |
12:00 ET | 5109 | 28.09 |
12:02 ET | 1100 | 28.11 |
12:03 ET | 2168 | 28.105 |
12:05 ET | 500 | 28.1 |
12:07 ET | 3700 | 28.1 |
12:09 ET | 2950 | 28.105 |
12:12 ET | 12336 | 28.105 |
12:14 ET | 2900 | 28.095 |
12:16 ET | 7500 | 28.1 |
12:18 ET | 8128 | 28.07 |
12:20 ET | 4635 | 28.07 |
12:21 ET | 1000 | 28.075 |
12:23 ET | 2500 | 28.07 |
12:25 ET | 2114 | 28.08 |
12:27 ET | 573 | 28.08 |
12:30 ET | 1700 | 28.085 |
12:32 ET | 694 | 28.085 |
12:34 ET | 7860 | 28.08 |
12:36 ET | 1599 | 28.085 |
12:38 ET | 979 | 28.1 |
12:39 ET | 1641 | 28.125 |
12:41 ET | 3062 | 28.125 |
12:43 ET | 1416 | 28.12 |
12:48 ET | 600 | 28.125 |
12:50 ET | 4632 | 28.1 |
12:52 ET | 1364 | 28.105 |
12:54 ET | 1000 | 28.105 |
12:56 ET | 2491 | 28.095 |
12:57 ET | 200 | 28.095 |
12:59 ET | 1781 | 28.105 |
01:01 ET | 2518 | 28.095 |
01:03 ET | 2484 | 28.0908 |
01:06 ET | 935 | 28.11 |
01:08 ET | 4517 | 28.14 |
01:10 ET | 1715 | 28.15 |
01:12 ET | 2787 | 28.15 |
01:14 ET | 3101 | 28.155 |
01:15 ET | 400 | 28.155 |
01:17 ET | 4249 | 28.15 |
01:19 ET | 1300 | 28.18 |
01:21 ET | 2476 | 28.165 |
01:24 ET | 715 | 28.17 |
01:26 ET | 3135 | 28.18 |
01:28 ET | 651 | 28.175 |
01:32 ET | 2202 | 28.155 |
01:35 ET | 300 | 28.155 |
01:37 ET | 400 | 28.17 |
01:39 ET | 2557 | 28.165 |
01:42 ET | 400 | 28.17 |
01:44 ET | 2474 | 28.175 |
01:46 ET | 1200 | 28.175 |
01:48 ET | 1610 | 28.165 |
01:50 ET | 4278 | 28.17 |
01:51 ET | 308 | 28.165 |
01:53 ET | 2702 | 28.155 |
01:55 ET | 2235 | 28.145 |
01:57 ET | 8649 | 28.165 |
02:00 ET | 331 | 28.17 |
02:02 ET | 688 | 28.175 |
02:04 ET | 2237 | 28.16 |
02:06 ET | 2376 | 28.15 |
02:08 ET | 616 | 28.15 |
02:09 ET | 3664 | 28.15 |
02:11 ET | 955 | 28.165 |
02:13 ET | 1746 | 28.16 |
02:15 ET | 1779 | 28.135 |
02:18 ET | 1622 | 28.1299 |
02:20 ET | 6403 | 28.12 |
02:22 ET | 1384 | 28.1 |
02:24 ET | 1405 | 28.085 |
02:26 ET | 1982 | 28.07 |
02:27 ET | 1790 | 28.08 |
02:29 ET | 719 | 28.09 |
02:31 ET | 200 | 28.09 |
02:33 ET | 888 | 28.09 |
02:36 ET | 1746 | 28.115 |
02:38 ET | 1106 | 28.12 |
02:40 ET | 850 | 28.13 |
02:42 ET | 450 | 28.14 |
02:44 ET | 4251 | 28.13 |
02:45 ET | 400 | 28.135 |
02:47 ET | 2248 | 28.155 |
02:49 ET | 200 | 28.155 |
02:51 ET | 200 | 28.155 |
02:54 ET | 2880 | 28.16 |
02:56 ET | 1407 | 28.155 |
02:58 ET | 723 | 28.1693 |
03:00 ET | 3232 | 28.155 |
03:02 ET | 1500 | 28.125 |
03:03 ET | 788 | 28.145 |
03:05 ET | 200 | 28.14 |
03:07 ET | 731 | 28.155 |
03:09 ET | 2613 | 28.145 |
03:14 ET | 2262 | 28.14 |
03:16 ET | 849 | 28.155 |
03:18 ET | 830 | 28.155 |
03:20 ET | 7941 | 28.16 |
03:21 ET | 300 | 28.1601 |
03:23 ET | 2140 | 28.16 |
03:25 ET | 3635 | 28.14 |
03:27 ET | 1562 | 28.155 |
03:30 ET | 2954 | 28.135 |
03:32 ET | 2402 | 28.16 |
03:34 ET | 8273 | 28.16 |
03:36 ET | 1388 | 28.15 |
03:38 ET | 939 | 28.17 |
03:39 ET | 1100 | 28.165 |
03:41 ET | 341 | 28.165 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.6B | 18.7x | +1.83% |
Amneal Pharmaceuticals Inc | 2.7B | -13.3x | --- |
Endo Inc | 2.0B | 0.4x | --- |
Catalent Inc | 10.9B | -10.4x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 19.1x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.6B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.7x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | 19.7x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.